| 1.71 Data as of Jun 19 |  0.00 / 0.00%Today’s Change | 1.08 Today|||52-Week Range 4.95 | +20.42% Year-to-Date |
| Previous close | 1.71 |
| Today’s open | n.a. |
| Day’s range | -- - -- |
| Volume | 9,089 |
| Average volume (3 months) | 1,612,029 |
| Market cap | $90.9M |
| Dividend yield | -- |
| Earnings growth (last year) | +37.30% |
| Earnings growth (this year) | +42.41% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +33.85% |
| P/E ratio | NM |
| Price/Sales | 2.67 |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| CURNeuralstem Inc | 0.00 | 0.00% |
| PSDVpSivida Corp | 0.00 | 0.00% |
| AGENAgenus Inc | 0.00 | 0.00% |
| PTIEPain Therapeutics In... | 0.00 | 0.00% |
| Next reporting date | August 6, 2013 |
| EPS forecast (this quarter) | -$0.14 |
| Annual revenue (last year) | $26.3M |
| Annual profit (last year) | -$39.1M |
| Net profit margin | -148.64% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Jon P. Stonehouse |
Chief Financial Officer, Treasurer, CAO & SVP Thomas R. Staab, II, CPA |
Corporate headquarters Birmingham, Alabama |
.
